News

MLM Medical Labs, based in Moenchengladbach, Germany, and Cenetron Central Laboratories, located in Austin, Texas, USA, jointly announced today a strategic alliance, formed to provide their pharmaceutical and CRO clients with integrated central laboratory services for global clinical trials.

Cenetron Central Laboratories is a premier provider of molecular and general laboratory services. Founded in 1995, Cenetron has supported pivotal global trials in North America, Europe, Africa, and the Pacific Rim.  Cenetron’s client list includes leading pharmaceutical clients in the United States and Europe.

MLM and Cenetron will offer seamless laboratory testing for European and North American client sites, with harmonized custom kit design and construction, sample logistics, laboratory testing, and data management. ’ We are very impressed by the excellent match between both companies, Cenetron’s customer focus and its capabilities. Both companies are completely dedicated to clinical trials and managed by their owners. This will allow us to provide our clients with the same highly flexible and reliable central laboratory services in North America as they are used from our European trials.’ said Stephan Wnendt, CEO MLM.

Dwight DuBois, Cenetron’s CEO commented, ‘We are extremely pleased to form a partnership with MLM Medical Labs in order to expand the breadth and depth of our laboratory services.   Cenetron and MLM share a work culture that fosters a high level of expertise, a commitment to quality, and excellent customer service.  We have complete confidence in the infrastructure, the processes, and most importantly, the people at MLM.’

For further information please contact Dr. Katja Neuer under kneuer@mlm-labs.com or +492161 4642 102